ES2110009T3 - Derivados de la estreptolisina o. - Google Patents

Derivados de la estreptolisina o.

Info

Publication number
ES2110009T3
ES2110009T3 ES92917536T ES92917536T ES2110009T3 ES 2110009 T3 ES2110009 T3 ES 2110009T3 ES 92917536 T ES92917536 T ES 92917536T ES 92917536 T ES92917536 T ES 92917536T ES 2110009 T3 ES2110009 T3 ES 2110009T3
Authority
ES
Spain
Prior art keywords
derivatives
streptolisin
hemolytic
streptolysin
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92917536T
Other languages
English (en)
Inventor
Craig W Adams
Eva Y Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Instruments Inc filed Critical Beckman Instruments Inc
Application granted granted Critical
Publication of ES2110009T3 publication Critical patent/ES2110009T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

EN ESTA INVENCION SE PUBLICAN LOS DERIVADOS DE ESTREPTOLISINA O QUE SE PRODUCEN MEDIANTE TECNICAS RECOMBINADORAS DE ADN. EN UNA MANIFESTACION EL DERIVADO ES SOLUBLE A LA EXPRESION Y TIENE UNA ACTIVIDAD HEMOLITICA ESPECIFICA DE APROXIMADAMENTE 3,6 X 10 4 UNIDADES HEMOLITICAS POR MILIGRAMO.
ES92917536T 1991-08-30 1992-07-31 Derivados de la estreptolisina o. Expired - Lifetime ES2110009T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/752,429 US5378620A (en) 1991-08-30 1991-08-30 Streptolysin O derivatives

Publications (1)

Publication Number Publication Date
ES2110009T3 true ES2110009T3 (es) 1998-02-01

Family

ID=25026299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92917536T Expired - Lifetime ES2110009T3 (es) 1991-08-30 1992-07-31 Derivados de la estreptolisina o.

Country Status (8)

Country Link
US (1) US5378620A (es)
EP (1) EP0555439B1 (es)
AT (1) ATE159293T1 (es)
AU (1) AU661028B2 (es)
CA (1) CA2094245C (es)
DE (1) DE69222749T2 (es)
ES (1) ES2110009T3 (es)
WO (1) WO1993005156A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4133707A1 (de) * 1991-10-11 1993-04-15 Behringwerke Ag Verfahren zur reinigung von streptolysin o, intaktes streptolysin o erhaeltlich nach diesem verfahren und seine verwendung
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium
US5576289A (en) * 1995-04-13 1996-11-19 Milkhaus Laboratory Methods for treating motor deficits
US6998121B2 (en) * 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
US5736508A (en) * 1997-03-04 1998-04-07 Milkhaus Laboratory, Inc. Methods for treatment of scar tissue
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
JP4875490B2 (ja) * 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20060165716A1 (en) * 2004-07-29 2006-07-27 Telford John L Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
WO2006042027A2 (en) * 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
US20080182789A1 (en) * 2007-01-30 2008-07-31 Milkhaus Laboratory, Inc. Method of treating pulmonary fibrosis
ATE522541T1 (de) * 2006-06-09 2011-09-15 Novartis Ag Bakterielle adhäsine konformere
AU2007348285A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
BRPI0821240B8 (pt) 2007-12-21 2022-10-04 Novartis Ag formas mutantes de estreptolisina o
TWI675032B (zh) 2014-10-14 2019-10-21 美商維它藥物公司 ＲＯＲ-γ之二氫吡咯并吡啶抑制劑
WO2017204325A1 (ja) 2016-05-27 2017-11-30 東洋紡株式会社 改変型ストレプトリジンｏ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925799A (en) * 1983-01-12 1990-05-15 The United States Of America As Represented By The Department Of Health And Human Services Plasmid cloning vector pAS1
GB8827038D0 (en) * 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
GB2233977B (en) * 1989-01-04 1993-03-31 Michael Kehoe Cytolytic streptolysin o mutants and uses

Also Published As

Publication number Publication date
US5378620A (en) 1995-01-03
ATE159293T1 (de) 1997-11-15
JP3595840B2 (ja) 2004-12-02
WO1993005156A1 (en) 1993-03-18
JPH06503003A (ja) 1994-04-07
EP0555439B1 (en) 1997-10-15
AU2437292A (en) 1993-04-05
CA2094245A1 (en) 1993-03-01
DE69222749T2 (de) 1998-02-26
AU661028B2 (en) 1995-07-13
EP0555439A1 (en) 1993-08-18
DE69222749D1 (de) 1997-11-20
CA2094245C (en) 2007-01-09

Similar Documents

Publication Publication Date Title
ATE159293T1 (de) Streptolysin o derivate
ES2082003T3 (es) Deshidrodidemnina b.
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
ES2099274T3 (es) Derivados de estreptolisina o.
KR900700567A (ko) 2,3-디플루오로비페닐
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
ATE111477T1 (de) 2'-halomethyliden, 2'-ethenyliden und 2'-ethynyl- adenosinderivate.
DE69201302D1 (de) Therapeutische zusammenstellungen auf der basis von 1,2-dithiole-3-thionderivaten.
FI912518A0 (fi) Modifiering av kaernan i superledande, en tennkaerna innehaollande materialer med en metallegering.
FI892387A7 (fi) Mellanprodukter foer framstaellning av 1,4-dihydro-4-oxokinolin-3-karboxylsyraestrar.
FI915125L (fi) Synergistiska kombinationer av idopropargylfoereningar med hexahydro-1,3,5-tris (2-hydroxietyl)-s -triazin foer kontroll av svamp- och bakterietillvaext i metallbearbetningsvaetskor.
FR2593066B1 (fr) Compositions therapeutiques a base de derives de 3-alkoxyflavones et nouveaux derives de 3-alkoxyflavones.
KR900700481A (ko) 1,4-치환된-2,3.5,6-테트라하이드로 [1,3,6]트리아조시노[1,2,-a] 벤즈이미다졸 및 이의 중간체
MA22143A1 (fr) Derives de 1,5 benzothiazepinone, leurs preparations et leur application
FI890483A7 (fi) Foerfarande foer framstaellning av sulfaterade alkanol- eller alkylfenoloxetylater med saenkt 1,4-dioxanhalt.
FI893366A0 (fi) 4-piperidylmetyl-2,3-dihydro-1h -isoindol- och 2,3,4,5-tetrahydro-1h-bensasepinderivat, deras framstaellning och terapeutiska anvaendning.
NO892772L (no) Nye 1,4-diazepinderivater med anti-ulcusaktivitet.
DK181089D0 (da) 1-dimethylcarbamoyl-3-substituerede-5-substituerede-1h-1,2,4-triazoler
RU1800124C (ru) Бытовой вентил тор
FI890658L (fi) Foerfarande foer framstaellning av 1,2-disulfonfoereningar.
IT8919498A0 (it) Derivati del 3,4 deidro piperidin 5 one ad attivita' erbicida.
ES1008510Y (es) Armario.
IT8819333A0 (it) 1,1 difluoroallil e 1,1difluoropropargil derivati.
IT9047758A0 (it) Estratto glicolipoproteico (cdsd90) da streptococcus termophilus ad attivita' immunomodulante ed antitumorale.
NO904154L (no) Terapeutisk anvendbare tetralinderivater.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555439

Country of ref document: ES